Additionally, we found that silencing of KRT7-AS notably increases KRT7 levels and enhances tumorigenic and anti-apoptotic effects in cancer cells; while overexpression of KRT7-AS reduces levels of oncogenic KRT7 in lung and breast cancer tissues and tumor cells, resulting in tumor suppression and pro-apoptosis effects. The gene discussed is KRT7; the disease is breast cancer.